Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapyJuanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2025
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapySian Cooper, Rosalyne L Westley, Katie Biscombe, et al.
The Lancet. Oncology|December 16, 2011
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis studyGillian C Barnett, Charlotte E Coles, Rebecca M Elliott, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
Nature Genetics|July 1, 2014
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancerQuesta Hope, Sarah Bullock, Christopher Evans, et al.
The Lancet. Oncology|June 15, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trialAlison C Tree, Victoria Hinder, Andrew Chan, et al.
The New England Journal of Medicine|October 16, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate CancerNicholas van As, Clare Griffin, Alison Tree, et al.
European Urology|October 8, 2024
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled TrialRobert Huddart, Shaista Hafeez, Clare Griffin, et al.
Pageof 27